Medpace Holdings, Inc. (NASDAQ:MEDP) Q3 2023 Earnings Call Transcript October 24, 2023 Operator: Good day, ladies and gentlemen, and welcome to the Medpace Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this call may be recorded. I would now like to introduce your host for today’s conference call, Lauren Morris, Medpace’s Director […]
Operator: Good day, ladies and gentlemen, and welcome to the Medpace Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this call may be recorded.
Industry veteran brings more than 30 years of operational experience, in large pharma and emerging stage biotech, private and public companies, with extensive commercial experience and an established track record of financing in the capital markets Lerodalcibep, a novel, next generation PCSK9 inhibitor and the.